24/07/2014
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers from the Universitat Politècnica de Catalunya - BarcelonaTech (UPC), the Institute of Medical Chemistry (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria. They have analysed the crystalline structure of the DNA with the drug by performing X-ray diffraction experiments at the ALBA Synchrotron. This work has been published in the journal Acta Crystallographica D.
Read the full press release published by the ALBA Synchrotron
Read the full press release published by the ALBA Synchrotron
More news
08/01/2016
Spanish Duathlon Championships: Not Only Electrons Run Around the Barcelona Synchrotron Park
17/12/2015
Catalonia, Top Continental Europe Region in R&D Foreign Investments Attraction
11/12/2015
4th PRUAB Generating Ideas Programme: and the Winners are…
03/12/2015
SENER Technologies in the News
25/11/2015
Applus+ further strengthens its presence in the aerospace industry
18/11/2015
Barcelona Attractiveness Confirmed by Two International Rankings